When James Norris, a 56-year-old mechanic from Roxbury, New Jersey, went on a low dose of Mounjaro, a GLP-1 medication similar to Ozempic, to lose weight in March 2023, he thought it would be a ...

Shares of Novo Nordisk A/S were getting hit hard Monday, after the maker of Ozempic and Wegovy, the diabetes and obesity treatments, revealed data showing that its new weight-loss drug candidate ...

People taking blockbuster weight loss drugs say their exes have slipped back into their DMs after they lost weight. One in five people who slimmed down using Ozempic or similar shots said old ...

Filmmaker Karan Johar finally opened up about his drastic weight loss transformation. At the IIFA Digital Awards last week, he addressed the speculations about using Ozempic (a diabetic medication ...

Why some health groups are banding together to push for a range of obesity-care options in workplace-sponsored insurance.

Karan Johar’s dramatic weight loss has left fans amazed, sparking Ozempic speculation. Addressing the rumours on Saturday night, the 52-year-old filmmaker denied using the drug and credited his ...

Some speculate that he might be using Ozempic, a drug often associated with fast weight loss. In his Instagram post, Karan addressed these rumours head-on. Sharing a screenshot from X (formerly ...

Ozempic, a drug used to control blood sugar levels in diabetics, has now become a popular but controversial weight-loss tool among celebrities and socialites. Users say it curbs hunger and results ...

CagriSema, which is a combination of cagrilintide 2.4-milligram and semaglutide 2.4-mg doses, is being developed so people have a better choice for a weight-loss drug when the patents on Ozempic ...

New trial data showed CagriSema led to “superior” weight loss, but at a rate much less than original expectations of 25%.

Infowars host Alex Jones has finally addressed long standing rumors that he used Ozempic to lose weight. Speculation has run rife on social media for months now that the notorious conspiracy ...

New trial data showed CagriSema led to 'superior' weight loss, but at a rate less than expectations Shares of Novo Nordisk A/S were getting hit hard Monday, after the maker of Ozempic and Wegovy ...